Clinical trial registry data · Research · Transparency · Intelligence Independent research platform

ECRI — Methodology & Disclosure

What the model estimates

Execution costs inferred from published or transparently adjusted benchmark parameters. These values are not audited actual expenditure, trial funding, market size or total development cost.

Formula: C = F + N × P + S × A + M + L.

F: fixed startup/administration; N: target participants; P: variable cost per participant; S: sites; A: fixed cost per site; M: monitoring/data management; L: logistics and study-specific costs.

Inputs are selected by validated applicability. Overlapping cost scopes are rejected to prevent double counting. Missing site or participant information is never interpreted as zero. Lower/upper values, where supported, are sensitivity bounds, not confidence intervals.

No active scientific model has been published. Sources and parameters undergoing administrative review are deliberately not presented as active methodology.

Trial-specific provenance is disclosed only for estimates that have been independently validated and published.